TEVA שווי כולל של נכסי החברה Teva

Teva Pharmaceutical Industries (TEVA) operates within the mass generics environment, leveraging large-scale capacities and pharmacy partnerships despite FDA oversight and ongoing litigation. This chart of the company's price action on GURU.Markets shows total assets at 39887.01, while the business generates revenue from the sale of affordable generic drug copies and original CNS treatments. Growth is driven by the Pivot to Growth strategy, debt reduction, and the launch of new drugs.

Teva Pharmaceutical Industries (TEVA) maintains a strong position driven by global demand for affordable generics, which serve as a steady cash generator. This indicator, calculated inversely via ROA, measures the company's total resource base, including equity and liabilities. The total asset valuation of 39887.01 confirms the scale of the company's production capacities. Growth in this metric, coupled with stable asset returns, signals the long-term sustainability of the business.